←Back to Expert Scholars
Translational Medicine / 转化医学Cancer Splicing Modulators
Lorena Lerner
PhD
🏢Remix Therapeutics🌐USA
Chief Scientific Officer
25
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Lorena Lerner leads scientific strategy at Remix Therapeutics, a company developing small molecule RNA splicing and processing modulators for cancer. Her work advances the concept of drugging RNA regulation for therapeutic benefit. She is a leading figure in the emerging RNA-targeted small molecule field.
Share:
🧪Research Fields 研究领域
RNA splicing drug discovery
cancer splicing regulators
small molecule splicing modulators
oncology drug discovery
RNA targeted therapy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Lorena Lerner 的研究动态
Follow Lorena Lerner's research updates
留下邮箱，当我们发布与 Lorena Lerner（Remix Therapeutics）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment